Document:

Exhibit 10.5

 

SUBSCRIPTION AGREEMENT

 

		TO:	The Directors of Viveon Health Acquisition Corp. (the
“Company”).

 

The undersigned hereby subscribes for 3,593,750 shares of common
stock, par value $0.0001 per share (the “Shares”) of the Company. In consideration for the issue of the Shares, the
undersigned hereby agrees and undertakes to pay $25,000 to the Company.

 

The undersigned agrees to take the Shares subject to the Certificate
of Incorporation of the Company and authorizes you to enter the following name and address in the stockholder ledger of the Company:

 

	 	Name:	Viveon Health LLC
		Address:	1860 Childers Place NE

Atlanta, GA 30324

 

Viveon Health LLC

 

Signed:

	Name:	Romilos Papadopoulos
	Title:	Managing Member

 

		Dated:	August 8, 2020

 

Accepted:

 

Viveon Health Acquisition Corp.

 

Signed:

	Name:	Jagi Gill
	Title:	Chief Executive Officer

 

		Dated:	August 8, 2020Exhibit
10.6

 

STOCK
ESCROW AGREEMENT

 

STOCK
ESCROW AGREEMENT, dated as of [●], 2020 (“Agreement”), by and among Viveon Health Acquisition Corp., a Delaware
corporation (“Company”), the stockholders of the Company listed on Exhibit A hereto (the “Founders”) and
Continental Stock Transfer & Trust Company, a New York limited purpose trust company (“Escrow Agent”).

 

WHEREAS,
the Company was formed for the purpose of completing a merger, stock exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination (a “Business Combination”) with one or more businesses or entities.

 

WHEREAS,
the Company has entered into an Underwriting Agreement, dated [●], 2020 (“Underwriting Agreement”), with Chardan
Capital Markets LLC (the “Representative”) acting as representative of the several underwriters (collectively, the
“Underwriters”), pursuant to which, among other matters, the Underwriters have agreed to purchase 17,000,000 units
(“Units”) of the Company, plus up to an additional 2,550,000 Units if the Representative exercises the over-allotment
option in full. Each Unit consists of one share of the Company’s common stock, par value $0.0001 per share (“Common
Stock”), one redeemable warrant and one right. Each right (“Right”) entitles the holder thereof to receive one-twentieth
(1/20) of a share of Common Stock upon consummation of the Company’s initial Business Combination. Each warrant entitles
the holder to purchase one-half (1/2) of a share of Common Stock at a price of $11.50 per whole share subject to adjustment, all
as more fully described in the Company’s final Prospectus, dated [●], 2020 (“Prospectus”) comprising part
of the Company’s Registration Statement on Form S-1, File No. 333-251112 (“Registration Statement”), filed with
the Securities and Exchange Commission, under the Securities Act of 1933, as amended, declared effective on [●], 2020 (“Effective
Date”).

 

WHEREAS,
the Founders have agreed as a condition of the sale of the Units to deposit their shares of Common Stock of the Company in escrow
as hereinafter provided.

 

WHEREAS,
the Company and the Founders desire that the Escrow Agent accept the shares of Common Stock, in escrow, to be held and disbursed
as hereinafter provided.

 

IT
IS AGREED:

 

1. Appointment
of Escrow Agent. The Company and the Founders hereby appoint the Escrow Agent to act in accordance with and subject to the
terms of this Agreement and the Escrow Agent hereby accepts such appointment and agrees to act in accordance with and subject
to such terms.

 

2. Deposit
of Shares. On or before the Effective Date, the Founders’ respective shares of Common Stock set forth on Exhibit A hereto
shall be deposited in escrow, to be held and disbursed subject to the terms and conditions of this Agreement. The Founders acknowledge
that the shares deposited in escrow will be legended to reflect the deposit of such shares under this Agreement.

 

3. Disbursement
of the Escrow Shares.

 

3.1
(a) If the over-allotment option to purchase all or a portion of the additional 2,550,000 Units of the Company is not exercised
in full within 45 days of the date of the Prospectus (as described in the Underwriting Agreement), the Founders agree that the
Escrow Agent shall return to the Company for cancellation, at no cost, the number of shares of Common Stock determined by multiplying
637,500 by a fraction, (i) the numerator of which is 2,550,000 minus the number of shares of Common Stock included in the Units
purchased by the Underwriters upon the exercise of the over-allotment option, and (ii) the denominator of which is 2,550,000.
The Company shall promptly provide notice to the Escrow Agent of the expiration or termination of the over-allotment option and
the number of Units, if any, purchased by the Underwriters in connection with the exercise thereof.

 

     

     

    

 

(b)
The Founders agree that the Escrow Agent shall return to the Company for cancellation, at no cost, up to 977,500 Escrow Shares
(or 850,000 Escrow Shares to the extent that the underwriters’ over-allotment is not exercised, pro rata) to the extent
that Rights are exercised upon the consummation of an initial Business Combination, as described in the Prospectus.

 

3.2
Except as otherwise set forth herein, the Escrow Agent shall hold the shares remaining after any cancellation required pursuant
to Section 3.1 above (such remaining shares to be referred to herein as the “Escrow Shares”) until (i) with respect
to 50% of the Escrow Shares, the earlier of six months after the date of the consummation of an initial Business Combination,
and the date on which the closing price of the Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period following the
consummation of the Business Combination, and (ii) with respect to the remaining 50% of the Escrow Shares, six months after the
date of the consummation of an initial Business Combination or (iii) earlier, in either case if, after the consummation of an
initial Business Combination, there is a consummation of a liquidation, merger, stock exchange or other similar transaction which
results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities,
or other property (such period of time during which the Escrow Shares are held in escrow, the “Escrow Period”). Upon
the achievement of any of the conditions set forth above, the Company shall promptly provide notice to the Escrow Agent, in form
reasonably acceptable to the Escrow Agent. Upon completion of the Escrow Period, the Escrow Agent shall disburse such amount of
each Founder’s Escrow Shares to the applicable Founder. The Escrow Agent shall have no further duties hereunder after the
disbursement of the Escrow Shares in accordance with this Section 3.2.

 

3.3 Notwithstanding
the provisions of Section 3.2, if the Escrow Agent is notified by the Company pursuant to Section 6.7 hereof that the Company’s
Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the
Company and the Escrow Agent as trustee thereunder) is being liquidated, then the Escrow Agent shall deliver the certificates
representing the Escrow Shares to the Founders promptly after the public stockholders are paid the liquidating distributions and
shall have no further duties hereunder.

 

4. Rights
of Founders in Escrow Shares.

 

4.1 Voting
Rights as a Stockholder. Subject to the terms of the Insider Letters described in Section 4.4 hereof and except as herein
provided, the Founders shall retain all of their rights as stockholders of the Company as long as any shares are held in escrow
pursuant to this Agreement, including, without limitation, the right to vote such shares.

 

4.2 Dividends
and Other Distributions in Respect of the Escrow Shares. For as long as any shares are held in escrow pursuant to this Agreement,
all dividends payable in cash with respect to the Escrow Shares shall be paid to the Founders, but all dividends payable in stock
or other non-cash property (“Non-Cash Dividends”) shall be delivered to the Escrow Agent to hold in accordance with
the terms hereof. As used herein, the term “Escrow Shares” shall be deemed to include the Non-Cash Dividends distributed
thereon, if any.

 

4.3 Restrictions
on Transfer. During the Escrow Period, the only permitted transfers of the Escrow Shares will be (i) to officers, directors,
consultants or affiliates of the Founders or the Company, (ii) to a Founder’s stockholders, partners or members upon such
Founder’s liquidation, (iii) by bona fide gift to a member of the Founders’ immediate family or to a trust, the beneficiary
of which is a Founder or a member of a Founder’s immediate family for estate planning purposes, (iv) by virtue of the laws
of descent and distribution upon death of a Founder, (v) pursuant to a qualified domestic relations order binding on a Founder,
(vi) to the Company for no value for cancellation in connection with the consummation of a Business Combination (vii) by private
sales of the Escrow Shares made at or prior to the consummation of a Business Combination at prices no greater than the price
at which the Escrow Shares were originally purchased or (viii) by private sales in connection with the consummation of our initial
Business Combination; provided, however, that except for clause (vi) or with the Company’s prior written consent, such permitted
transfers may be implemented only upon the respective transferee’s written agreement to be bound by the terms and conditions
of this Agreement and of the Insider Letter signed by the Founder transferring the shares.

 

4.4 Insider
Letters. The Founders have executed letter agreements with the Company and the Representative, dated as of the date hereto,
the form of which is filed as an exhibit to the Registration Statement (“Insider Letter”), respecting the rights and
obligations of such Founders in certain events, including, but not limited to, the liquidation of the Company.

 

    	 	2	 

     

    

 

5. Concerning
the Escrow Agent.

 

5.1 Good
Faith Reliance. The Escrow Agent shall not be liable for any action taken or omitted by it in good faith and in the exercise
of its own best judgment, and may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate,
opinion or advice of counsel (including counsel chosen by the Escrow Agent), statement, instrument, report or other paper or document
(not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability
of any information therein contained) which is believed by the Escrow Agent in good faith to be genuine and to be signed or presented
by the proper person or persons. The Escrow Agent shall not be bound by any notice or demand, or any waiver, modification, termination
or rescission of this Agreement unless evidenced by a writing delivered to the Escrow Agent signed by the proper party or parties
and, if the duties or rights of the Escrow Agent are affected, unless it shall have given its prior written consent thereto.

 

5.2 Indemnification.
Subject to Section 5.8 below, the Escrow Agent shall be indemnified and held harmless by the Company from and against any expenses,
including reasonable counsel fees and disbursements, or loss suffered by the Escrow Agent in connection with any action, suit
or other proceeding involving any claim which in any way, directly or indirectly, arises out of or relates to this Agreement,
the services of the Escrow Agent hereunder, or the Escrow Shares held by it hereunder, other than expenses or losses arising from
the gross negligence, fraud or willful misconduct of the Escrow Agent. Promptly after the receipt by the Escrow Agent of notice
of any demand or claim or the commencement of any action, suit or proceeding, the Escrow Agent shall notify the other parties
hereto in writing. In the event of the receipt of such notice, the Escrow Agent, in its sole discretion, may commence an action
in the nature of interpleader in an appropriate court to determine ownership or disposition of the Escrow Shares or it may deposit
the Escrow Shares with the clerk of any appropriate court or it may retain the Escrow Shares pending receipt of a final, non-appealable
order of a court having jurisdiction over all of the parties hereto directing to whom and under what circumstances the Escrow
Shares are to be disbursed and delivered. The provisions of this Section 5.2 shall survive in the event the Escrow Agent resigns
or is discharged pursuant to Sections 5.5 or 5.6 below.

 

5.3 Compensation.
Subject to Section 5.8 below, the Escrow Agent shall be entitled to reasonable compensation from the Company for all services
rendered by it hereunder. The Escrow Agent shall also be entitled to reimbursement from the Company for all reasonable expenses
paid or incurred by it in the administration of its duties hereunder including, but not limited to, all counsel, advisors’
and agents’ fees and disbursements and all taxes or other governmental charges.

 

5.4 Further
Assurances. From time to time on and after the date hereof, the Company and the Founders shall deliver or cause to be delivered
to the Escrow Agent such further documents and instruments and shall do or cause to be done such further acts as the Escrow Agent
shall reasonably request to carry out more effectively the provisions and purposes of this Agreement, to evidence compliance herewith
or to assure itself that it is protected in acting hereunder.

 

5.5 Resignation.
The Escrow Agent may resign at any time and be discharged from its duties as escrow agent hereunder by its giving the other parties
hereto written notice and such resignation shall become effective as hereinafter provided. Such resignation shall become effective
at such time that the Escrow Agent shall turn the Escrow Shares over to a successor escrow agent appointed by the Company and
approved by the Representative, which approval will not be unreasonably withheld, conditioned or delayed. If no new escrow agent
is so appointed within the 60-day period following the giving of such notice of resignation, the Escrow Agent may deposit the
Escrow Shares with any court it reasonably deems appropriate in the State of New York.

 

5.6 Discharge
of Escrow Agent. The Escrow Agent shall resign and be discharged from its duties as escrow agent hereunder if so requested
in writing at any time by all of the other parties hereto; provided, however, that such resignation shall become effective only
upon the appointment of a successor escrow agent selected by the Company and approved by the Representative, which approval will
not be unreasonably withheld, conditioned or delayed.

 

    	 	3	 

     

    

 

5.7 Liability.
Notwithstanding anything herein to the contrary, the Escrow Agent shall not be relieved from liability hereunder for its own gross
negligence, fraud or willful misconduct.

 

5.8 Waiver.
The Escrow Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in, or to any distribution of, the Trust Account and hereby agrees not to seek recourse, reimbursement, payment or satisfaction
for any Claim against the Trust Account for any reason whatsoever.

 

6. Miscellaneous.

 

6.1 Governing
Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York,
without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, Borough
of Manhattan, for purposes of resolving any disputes hereunder. As to any claim, cross-claim, or counterclaim in any way relating
to this Agreement, each party waives the right to trial by jury.

 

6.2 Third
Party Beneficiaries. Each of the parties to this Agreement hereby acknowledges that the Representative is a third party beneficiary
of this Agreement.

 

6.3 Entire
Agreement. This Agreement contains the entire agreement of the parties hereto with respect to the subject matter hereof and,
except as expressly provided herein, may only be changed, amended, or modified by a writing signed by each of the parties
hereto.

 

6.4 Headings.
The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
thereof.

 

6.5 Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the respective parties hereto and their legal representatives,
successors and assigns.

 

6.6 Notices.
Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing
and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery,
by email or by facsimile transmission:

 

If
to the Company, to:

 

Viveon
Health Acquisition Corp

c/o Gibson, Deal & Fletcher, PC

Spalding Exchange

3953 Holcomb Bridge Road

Suite 200

Norcross Georgia 30092

Attn: Jagi Gill

Email: jgill@viveonhealth.com

 

If
to a Founder, to his/her/its address set forth in Exhibit A.

 

and
if to the Escrow Agent, to:

 

Continental
Stock Transfer & Trust Company

1
State Street, 30th Floor

New
York, New York 10004

Attn:
Client Administration Dept.

Email:
accountadmin@continentalstock.com

 

    	 	4	 

     

    

 

A
copy of any notice sent hereunder shall be sent to:

 

Chardan
Capital Markets, LLC

17 State Street, Suite 1600

New York, NY 10004

Attn: George Kaufman

Facsimile: ([•]) [•]-[•]

Email: gkaufman@chardancm.com

 

with
a copy to:

 

White
& Williams LLP

7 Times Square, Suite 2900

New
York, NY 10036-6524

Attn: Alexandria E. Kane

Fax No.: (212) 631-4409

Email: kanea@whiteandwilliams.com

 

and:

 

Loeb
& Loeb LLP

345 Park Avenue

New York, NY 10154

Attn: Mitchell S. Nussbaum

Fax No.: (212) 407-4990

Email: mnussbaum@loeb.com

 

The
parties may change the persons and addresses to which the notices or other communications are to be sent by giving written notice
to any such change in the manner provided herein for giving notice.

 

6.7 Liquidation
of the Trust Account. The Company shall give the Escrow Agent written notification of the liquidation of the Trust Account
in the event that the Company fails to consummate a Business Combination within the time period specified in the Company’s
Amended and Restated Certificate of Incorporation, as the same may be amended from time to time.

 

6.8 Counterparts.
This Agreement may be executed in several counterparts, each one of which shall constitute an original and may be delivered by
facsimile transmission and together shall constitute one instrument.

 

[Signature
Page Follows]

 

    	 	5	 

     

    

 

WITNESS
the execution of this Agreement as of the date first above written.

 

	 	VIVEON HEALTH ACQUISITION CORP.. 
	 	 
	 	By:	 
	 	Name:	Jagi Gill
	 	Title:	Chief Executive Officer
	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY 
	 	 
	 	By:	 
	 	Name:	Francis E. Wolf,
Jr. 
	 	Title:	Vice President

 

	 	FOUNDERS:
	 	 	 
	 	VIVEON HEALTH LLC
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	 
	 	Name:
	 	 
	 	Name:
	 	 
	 	Name:

 

[Signature
Page to Stock Escrow Agreement]

 

    	 	6	 

     

    

 

EXHIBIT
A

 

	Name and Address of Founder	 	Number of Shares	 
	Viveon Health LLC

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]